| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Revenue | $5.5M | +102.2% |
| Cost of Revenue | $2.7M | +8.1% |
| Gross Profit | $2.8M | +1097.5% |
| R&D Expense | $7.7M | -23.0% |
| Operating Income | -$29.3M | -0.4% |
| Pre-tax Income | -$28.7M | -8.0% |
| Income Tax | -$1.3M | -351.1% |
| Net Income | -$27.5M | -4.4% |
| EPS (Basic) | -$0.47 |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.2M | -54.2% |
| Short-term Investments | $27.8M | +0.0% |
| Accounts Receivable | $796K | +6.8% |
| Inventory | $4.8M | +362.7% |
| Current Assets | $10.5M | -72.0% |
| Total Assets | $28.7M | -46.2% |
| Current Liabilities | $7.4M | -6.9% |
| Line Item | 2024-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.8M | -37.1% |
| Capital Expenditures | $2.6M | +298.9% |
| Investing Cash Flow | $25.5M | +24.6% |
| Financing Cash Flow | $469K | +3450.0% |
| Free Cash Flow | -$32.3M | -44.7% |
| +0.0% |
| EPS (Diluted) | -$0.47 | +0.0% |
| Total Liabilities |
| $9.4M |
| -0.6% |
| Stockholders' Equity | $19.3M | -56.0% |